138 related articles for article (PubMed ID: 11478589)
21. Role of thromboxane A2 in early BDL-induced portal hypertension.
Yokoyama Y; Xu H; Kresge N; Keller S; Sarmadi AH; Baveja R; Clemens MG; Zhang JX
Am J Physiol Gastrointest Liver Physiol; 2003 Mar; 284(3):G453-60. PubMed ID: 12431905
[TBL] [Abstract][Full Text] [Related]
22. Vasopressin response and shunting modulation in cirrhotic rats by chronic nitric oxide inhibition.
Huang HC; Wang SS; Lee FY; Chang CC; Chang FY; Lin HC; Hou MC; Lee SD
J Gastroenterol Hepatol; 2008 Jul; 23(7 Pt 2):e265-9. PubMed ID: 17764528
[TBL] [Abstract][Full Text] [Related]
23. Depside salts from Salvia miltiorrhiza improve myocardial microperfusion in rats using laser Doppler flowmetry.
Li XF; Wang YP
Acta Pharmacol Sin; 2007 Jun; 28(6):789-95. PubMed ID: 17506937
[TBL] [Abstract][Full Text] [Related]
24. Lack of effect of norfloxacin on hyperdynamic circulation in bile duct-ligated rats despite reduction of endothelial nitric oxide synthase function: result of unchanged vascular Rho-kinase?
Hennenberg M; Trebicka J; Buecher D; Heller J; Sauerbruch T
Liver Int; 2009 Jul; 29(6):933-41. PubMed ID: 19490424
[TBL] [Abstract][Full Text] [Related]
25. Splenic hemodynamics and decreased endothelial nitric oxide synthase in the spleen of rats with liver cirrhosis.
Yamaguchi S; Kawanaka H; Yoshida D; Maehara Y; Hashizume M
Life Sci; 2007 May; 80(22):2036-44. PubMed ID: 17481668
[TBL] [Abstract][Full Text] [Related]
26. Vasoactive intestinal peptide in cirrhotic rats: hemodynamic effects and mesenteric arterial receptor characteristics.
Lee SS; Huang M; Ma Z; Rorstad O
Hepatology; 1996 May; 23(5):1174-80. PubMed ID: 8621151
[TBL] [Abstract][Full Text] [Related]
27. Effects of the combined administration of propranolol plus sorafenib on portal hypertension in cirrhotic rats.
D'Amico M; Mejías M; García-Pras E; Abraldes JG; García-Pagán JC; Fernández M; Bosch J
Am J Physiol Gastrointest Liver Physiol; 2012 May; 302(10):G1191-8. PubMed ID: 22403792
[TBL] [Abstract][Full Text] [Related]
28. Nitric oxide and vascular remodeling modulate hepatic arterial vascular resistance in the isolated perfused cirrhotic rat liver.
Zipprich A; Loureiro-Silva MR; Jain D; D'Silva I; Groszmann RJ
J Hepatol; 2008 Nov; 49(5):739-45. PubMed ID: 18804307
[TBL] [Abstract][Full Text] [Related]
29. Cediranib ameliorates portal hypertensive syndrome via inhibition of VEGFR-2 signaling in cirrhotic rats.
Fan Q; Wu G; Chen M; Luo G; Wu Z; Huo H; Li H; Zheng L; Luo M
Eur J Pharmacol; 2024 Feb; 964():176278. PubMed ID: 38158116
[TBL] [Abstract][Full Text] [Related]
30. Chronic administration of ursodeoxycholic acid decreases portal pressure in rats with biliary cirrhosis.
Yang YY; Huang YT; Lee KC; Lee FY; Lee TY; Hou MC; Lin HC; Lee SD
Clin Sci (Lond); 2009 Jan; 116(1):71-9. PubMed ID: 18479249
[TBL] [Abstract][Full Text] [Related]
31. Effects of simvastatin, pentoxifylline and spironolactone on hepatic fibrosis and portal hypertension in rats with bile duct ligation.
Oberti F; Pilette C; Rifflet H; Maïga MY; Moreau A; Gallois Y; Girault A; le Bouil A; Le Jeune JJ; Saumet JL; Feldmann G; Calès P
J Hepatol; 1997 Jun; 26(6):1363-71. PubMed ID: 9210625
[TBL] [Abstract][Full Text] [Related]
32. [Effects of radix Salviae miltiorrhizae on hemodynamics of portal hypertension: clinical and experimental study].
Li X; Yao X; Li T
Zhonghua Nei Ke Za Zhi; 1997 Jul; 36(7):450-3. PubMed ID: 10436944
[TBL] [Abstract][Full Text] [Related]
33. Antifibrotic and hemodynamic effects of the early and chronic administration of octreotide in two models of liver fibrosis in rats.
Fort J; Oberti F; Pilette C; Veal N; Gallois Y; Douay O; Rousselet MC; Rosenbaum J; Calès P
Hepatology; 1998 Dec; 28(6):1525-31. PubMed ID: 9828216
[TBL] [Abstract][Full Text] [Related]
34. Salvia miltiorrhiza inhibits biliary obstruction-induced hepatocyte apoptosis by cytoplasmic sequestration of p53.
Oh SH; Nan JX; Sohn D-; Kim YC; Lee BH
Toxicol Appl Pharmacol; 2002 Jul; 182(1):27-33. PubMed ID: 12127260
[TBL] [Abstract][Full Text] [Related]
35. The effects of proton pump inhibitor on hepatic vascular responsiveness and hemodynamics in cirrhotic rats.
Hsin IF; Hsu SJ; Chuang CL; Huo TI; Huang HC; Lee FY; Ho HL; Chang SY; Lee SD
J Chin Med Assoc; 2018 Jul; 81(7):585-592. PubMed ID: 29780000
[TBL] [Abstract][Full Text] [Related]
36. [Amelioration of carbon tetrachloride-induced hepatic fibrosis in rats by treatment with salvia miltiorrhiza and taurine].
Chen Y; Li S; Zhang X; Zhang Z; Xie W
Zhonghua Gan Zang Bing Za Zhi; 2002 Apr; 10(2):148-9. PubMed ID: 11983142
[No Abstract] [Full Text] [Related]
37. [Influence of Salvia miltiorrhizae and Astragalus membranaceus on hemodynamics and liver fibrosis indexes in liver cirrhotic patients with portal hypertension].
Tan YW; Yin YM; Yu XJ
Zhongguo Zhong Xi Yi Jie He Za Zhi; 2001 May; 21(5):351-3. PubMed ID: 12577420
[TBL] [Abstract][Full Text] [Related]
38. Green tea polyphenol decreases the severity of portosystemic collaterals and mesenteric angiogenesis in rats with liver cirrhosis.
Hsu SJ; Wang SS; Hsin IF; Lee FY; Huang HC; Huo TI; Lee WS; Lin HC; Lee SD
Clin Sci (Lond); 2014 May; 126(9):633-44. PubMed ID: 24063570
[TBL] [Abstract][Full Text] [Related]
39. Improved hemodynamic and liver function in portal hypertensive cirrhotic rats after administration of B. pseudocatenulatum CECT 7765.
Gómez-Hurtado I; Zapater P; Portune K; Juanola O; Fernández-Iglesias A; González-Navajas JM; Gracia-Sancho J; Sanz Y; Francés R
Eur J Nutr; 2019 Jun; 58(4):1647-1658. PubMed ID: 29748815
[TBL] [Abstract][Full Text] [Related]
40. The anti-inflammatory effect of celecoxib does not prevent liver fibrosis in bile duct-ligated rats.
Yu J; Hui AY; Chu ES; Go MY; Cheung KF; Wu CW; Chan HL; Sung JJ
Liver Int; 2009 Jan; 29(1):25-36. PubMed ID: 18435714
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
